Anti-AKT3 + AKT1 antibody [E45]
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal AKT1 phospho S473 antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Recombinant fragment - Human, Human samples. Cited in 11 publications.
View Alternative Names
PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT3 + AKT1 antibody [E45] (AB32038)
Immunohistochemistry (Paraffin-embedded sections) analysis using ab32038 at a dilution of 1/1000 - 1/1250 and squamous lung carcinoma
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-AKT3 + AKT1 antibody [E45] (AB32038)
Immunocytochemistry/ Immunofluorescence analysis of SK-BR-3 (human breast adenocarcinoma epithelial cell) cells labeling AKT3+AKT1 with purified ab32038 at 1/500 dilution (2.1 μg/mL). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/mL). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/mL) was used as the secondary antibody only control.
- WB
Lab
Western blot - Anti-AKT3 + AKT1 antibody [E45] (AB32038)
Blocking/Diluting buffer : 5% NFDM/TBST.
Observed band : 82kDa, 56kDa.
82kDa band represents GFP tagged AKT. 56kDa band represents endogenous AKT.
All lanes:
Western blot - Anti-AKT3 + AKT1 antibody [E45] (ab32038) at 1/10000 dilution
Lane 1:
GFP tagged AKT1 transfected 293T cell lysate at 10 µg
Lanes 2, 4 and 6:
Empty vector transfected 293T cell lysate at 10 µg
Lane 3:
GFP tagged AKT2 transfected 293T cell lysate at 10 µg
Lane 5:
GFP tagged AKT3 transfected 293T cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Exposure time: 1s
Related conjugates and formulations (1)
-
Anti-AKT3 + AKT1 antibody [E45] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AKT1 and AKT3 influence several cellular functions including growth proliferation and survival. They are part of a larger AKT family which includes AKT2 that participates in important signaling cascades. AKT3 shows significant activity in the nervous system and contributes to brain development. Through phosphorylation AKT1 and AKT3 activate or inhibit downstream targets including mTOR and GSK-3β affecting the cell cycle and metabolism.
Pathways
AKT1 and AKT3 are integral components of the PI3K/AKT signaling pathway. This pathway regulates diverse cellular processes including protein synthesis glucose metabolism and apoptosis. AKT1 and AKT3 interact closely with proteins like PI3K and PTEN which either activate or inhibit this signaling pathway. Additionally they link to the mTOR pathway modulating anabolic processes and energy utilization in response to growth factors.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Bioactive materials 21:483-498 PubMed36185739
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology, immunotherapy : CII 67:271-283 PubMed29090321
2017
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:33756-33769 PubMed28422711
2017
Applications
Unspecified application
Species
Unspecified reactive species
eLife 6: PubMed28440748
2017
Applications
WB
Species
Unspecified reactive species
Scientific reports 6:37213 PubMed27849011
2016
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 6:18815 PubMed26739898
2016
Applications
WB
Species
Human
The Journal of biological chemistry 290:6810-24 PubMed25605718
2015
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 11:857-64 PubMed25369801
2014
Applications
WB
Species
Human
Journal of neuropathology and experimental neurology 72:884-91 PubMed23965747
2013
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 110:E1083-91 PubMed23471984
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com